Insulin Glargine (U-300) Pens and Oracit
Determining the interaction of Insulin Glargine (U-300) Pens and Oracit and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: citric acid / sodium citrate
Brand name: Bicitra, Cytra-2, Liqui-Dual Citra, Oracit, Shohl's Solution, Virtrate-2
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Orajel
- Insulin Glargine (U-300) Pens-Orajel Extra Strength
- Insulin Glargine (U-300) Pens-Oral Gel
- Insulin Glargine (U-300) Pens-Oralair
- Insulin Glargine (U-300) Pens-Oralair Adult Sample Kit
- Insulin Glargine (U-300) Pens-Oralair Childrens and Adolescents Sample Kit
- Oracit-Insulin glargine and lixisenatide
- Oracit-Insulin glargine and lixisenatide Subcutaneous
- Oracit-Insulin glargine, recombinant Subcutaneous
- Oracit-Insulin glulisine
- Oracit-Insulin Glulisine (Cartridges and Pens)
- Oracit-Insulin Glulisine (Vials)